As the fiscal year unfolds, companies have regulatory obligations, each with its deadlines and requirements. From disclosing related party transactions under sections 184 and 164 to reporting outstanding amounts to MSMEs and reconciling share capital audits, the ROC Compliance Calendar for 2024-25 is packed with crucial filings.
ROC Compliance Calendar (2024 – 25)
Sr. No. | Form | Particulars | Due Date |
1 | Disclosure u/s 184 and 164 | MBP-1 and DIR-8 | 01-04-2024 |
2 | MSME-1 (1st HY) | Reporting amount outstanding to MSME for more than 45 Days (HY) | 30-04-2024 (Oct 23 – Mar 24) |
3 | PAS-6 | To be filed by unlisted public co. for reconciliation of share capital audit report (HY) | 30-05-2024 (Oct 23 – Mar 24) |
4 | DPT-3 | Return of Deposit | 30-06-2024 |
5 | FLA | Annual Return to RBI (Unaudited) | 15-07-2024 |
6 | KYC | KYC of Directors | 30-09-2024 |
7 | FLA | Annual Return to RBI (Audited) | 30-09-2024 |
8 | Demat for Private Companies | Applying for ISIN | 30-09-2024 |
9 | MSME-1 (2nd HY) | Reporting amount outstanding to MSME for more than 45 Days (HY) | 31-10-2024 (Apr 24 – Sept 24) |
10 | PAS-6 | To be filed by unlisted public co. for reconciliation of share capital audit report (HY) | 29-11-2024 (Apr 24 – Sept 24) |
11 | MGT-14 | For Financial & Directors Report | Within 30 Days from BM |
12 | ADT-1 | Auditors Appointment/ Re-appointment | Within 15 Days of Appointment / Re-appointment |
13 | AOC-4 / AOC-4 (XBRL) | Financial Statement | Within 30 Days from AGM |
14 | MGT-7 / MGT-7A | Annual Return | Within 60 Days from AGM |
15 | CSR 2 | Reporting of CSR | 31st March 2025 |
Also Read: GST Compliances: Action Points of Closing of FY 2023-24
Staying ahead of these compliance deadlines Whether it’s filing annual returns, reconciling financial statements, or appointing auditors, timely adherence to these regulatory milestones strengthens the foundation of corporate governance. As the financial year progresses, companies must navigate these obligations diligently to uphold transparency, accountability, and regulatory integrity.
Disclaimer: This article provides general information existing at the time of preparation and we take no responsibility to update it with the subsequent changes in the law. The article is intended as a news update and Affluence Advisory neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this article. It is recommended that professional advice be taken based on specific facts and circumstances. This article does not substitute the need to refer to the original pronouncement
